4-Methylaminorex

4-Methylaminorex
Clinical data
Other names4-MAR; 4-MAX; McN-822; McN822
Routes of
administration
Oral, Vaporized, Insufflated, Injected
Legal status
Legal status
  • AU: S9 (Prohibited substance)
  • BR: Class F2 (Prohibited psychotropics)[1]
  • CA: Schedule III
  • DE: Anlage I (Authorized scientific use only)
  • UK: Class A
  • US: Schedule I
  • UN: Psychotropic Schedule I
Pharmacokinetic data
Bioavailability62% oral; 79% nasal; 91 - 93.5% smoked; 100% IV
MetabolismHepatic
Elimination half-life10-19 hours
ExcretionRenal
Identifiers
IUPAC name
  • 4-Methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H12N2O
Molar mass176.219 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
SMILES
  • CC1C(C2=CC=CC=C2)OC(N)=N1
InChI
  • InChI=1S/C10H12N2O/c1-7-9(13-10(11)12-7)8-5-3-2-4-6-8/h2-7,9H,1H3,(H2,11,12) Y
  • Key:LJQBMYDFWFGESC-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

4-Methylaminorex (4-MAR, 4-MAX) is a stimulant drug of the 2-amino-5-aryloxazoline group that was first synthesized in 1960 by McNeil Laboratories.[2] It is also known by its street name "U4Euh" ("Euphoria"). It is banned in many countries as a stimulant. 4-Methylaminorex has effects comparable to methamphetamine but with a longer duration.

  1. ^ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
  2. ^ US 3278382, "2-amino-5-aryloxazoline compositions and methods of using same"